CooperCompanies Announces Third Quarter 2024 Results

SAN RAMON, Calif., Aug. 28, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal third quarter ended July 31, 2024. % change y/y Revenue increased 8% year-over-year to $1,002.8 million. CooperVision (CVI) revenue up 7$675.6 million, and CooperSurgical (CSI) revenue up 9% to $327.2 million. GAAP diluted earnings per share (EPS) of$0.52, up $0.09 or 22$0. ...